Pages that link to "Q2208481"
Jump to navigation
Jump to search
The following pages link to Breast Cancer Research (Q2208481):
Displaying 50 items.
- Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours (Q21030553) (← links)
- Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes (Q21092901) (← links)
- Progestin effects on cell proliferation pathways in the postmenopausal mammary gland (Q21092903) (← links)
- Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome (Q21092905) (← links)
- The CD44+/CD24- phenotype is enriched in basal-like breast tumors (Q21092906) (← links)
- Key stages of mammary gland development: molecular mechanisms involved in the formation of the embryonic mammary gland (Q21092907) (← links)
- Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy (Q21146638) (← links)
- Cas proteins: dodgy scaffolding in breast cancer (Q21146639) (← links)
- Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships (Q21195153) (← links)
- Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival (Q21195154) (← links)
- Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses (Q21195155) (← links)
- Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway (Q21195156) (← links)
- Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells (Q21195157) (← links)
- Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis (Q21195159) (← links)
- Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu status (Q21195160) (← links)
- Cytochrome P450 1A2 (CYP1A2) activity, mammographic density, and oxidative stress: a cross-sectional study (Q21195169) (← links)
- Epidermal growth factor suppresses induction by progestin of the adhesion protein desmoplakin in T47D breast cancer cells (Q21195170) (← links)
- Identification of signaling pathways in early mammary gland development by mouse genetics (Q21195173) (← links)
- Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action (Q21195175) (← links)
- The thyroid, iodine and breast cancer (Q21195176) (← links)
- Beta class II tubulin predominates in normal and tumor breast tissues (Q21195178) (← links)
- Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland (Q21195180) (← links)
- Inflammatory breast cancer: clinical progress and the main problems that must be addressed (Q21195182) (← links)
- Adolescent diet and risk of breast cancer (Q21195184) (← links)
- Expression profiling predicts outcome in breast cancer (Q21195186) (← links)
- Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer. (Q21195187) (← links)
- Development of bisphosphonates (Q21195188) (← links)
- Amphiregulin mediates progesterone-induced mammary ductal development during puberty (Q21195190) (← links)
- Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide (Q21195191) (← links)
- Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes (Q21195193) (← links)
- Who's driving anyway? Herculean efforts to identify the drivers of breast cancer (Q21195195) (← links)
- Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members (Q21195197) (← links)
- Phenotypic and genetic alterations in mammary stroma: implications for tumour progression (Q21195198) (← links)
- Prolactin-induced protein mediates cell invasion and regulates integrin signaling in estrogen receptor-negative breast cancer (Q21195199) (← links)
- Vitamin D and the mammary gland: a review on its role in normal development and breast cancer (Q21195200) (← links)
- Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers (Q21195201) (← links)
- Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers (Q21195203) (← links)
- Molecular profiling of patient-derived breast cancer xenografts (Q21195204) (← links)
- CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen (Q21195205) (← links)
- Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin (Q21195209) (← links)
- MicroRNAs and their target gene networks in breast cancer (Q21195211) (← links)
- PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro (Q21195212) (← links)
- Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer (Q21195213) (← links)
- MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer (Q21195215) (← links)
- Underarm antiperspirants/deodorants and breast cancer (Q21195214) (← links)
- Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation (Q21195216) (← links)
- The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer (Q21195217) (← links)
- NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models (Q21195221) (← links)
- Breast cancer stroma frequently recruits fetal derived cells during pregnancy (Q21195222) (← links)
- BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype (Q21195223) (← links)